230 related articles for article (PubMed ID: 24365456)
1. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis.
Morgan VA; McGrath JJ; Jablensky A; Badcock JC; Waterreus A; Bush R; Carr V; Castle D; Cohen M; Galletly C; Harvey C; Hocking B; McGorry P; Neil AL; Saw S; Shah S; Stain HJ; Mackinnon A
Psychol Med; 2014 Jul; 44(10):2163-76. PubMed ID: 24365456
[TBL] [Abstract][Full Text] [Related]
2. People living with psychotic illness in 2010: the second Australian national survey of psychosis.
Morgan VA; Waterreus A; Jablensky A; Mackinnon A; McGrath JJ; Carr V; Bush R; Castle D; Cohen M; Harvey C; Galletly C; Stain HJ; Neil AL; McGorry P; Hocking B; Shah S; Saw S
Aust N Z J Psychiatry; 2012 Aug; 46(8):735-52. PubMed ID: 22696547
[TBL] [Abstract][Full Text] [Related]
3. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
[TBL] [Abstract][Full Text] [Related]
4. Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population.
Chang WC; Wong CSM; Chen EYH; Lam LCW; Chan WC; Ng RMK; Hung SF; Cheung EFC; Sham PC; Chiu HFK; Lam M; Lee EHM; Chiang TP; Chan LK; Lau GKW; Lee ATC; Leung GTY; Leung JSY; Lau JTF; van Os J; Lewis G; Bebbington P
Schizophr Bull; 2017 Oct; 43(6):1280-1290. PubMed ID: 28586480
[TBL] [Abstract][Full Text] [Related]
5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
6. Loneliness in psychotic disorders and its association with cognitive function and symptom profile.
Badcock JC; Shah S; Mackinnon A; Stain HJ; Galletly C; Jablensky A; Morgan VA
Schizophr Res; 2015 Dec; 169(1-3):268-273. PubMed ID: 26527247
[TBL] [Abstract][Full Text] [Related]
7. Common familial risk factors for schizophrenia and diabetes mellitus.
Foley DL; Mackinnon A; Morgan VA; Watts GF; Castle DJ; Waterreus A; Galletly CA
Aust N Z J Psychiatry; 2016 May; 50(5):488-94. PubMed ID: 26209325
[TBL] [Abstract][Full Text] [Related]
8. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis.
Cooper J; Mancuso SG; Borland R; Slade T; Galletly C; Castle D
Aust N Z J Psychiatry; 2012 Sep; 46(9):851-63. PubMed ID: 22645396
[TBL] [Abstract][Full Text] [Related]
9. No additive effect of cannabis on cognition in schizophrenia.
Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian National Survey of Psychosis.
Shah S; Mackinnon A; Galletly C; Carr V; McGrath JJ; Stain HJ; Castle D; Harvey C; Sweeney S; Morgan VA
Schizophr Res; 2014 Oct; 159(1):20-6. PubMed ID: 25107848
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis.
Galletly CA; Foley DL; Waterreus A; Watts GF; Castle DJ; McGrath JJ; Mackinnon A; Morgan VA
Aust N Z J Psychiatry; 2012 Aug; 46(8):753-61. PubMed ID: 22761397
[TBL] [Abstract][Full Text] [Related]
12. Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey.
Bosanac P; Mancuso SG; Castle DJ
Clin Schizophr Relat Psychoses; 2016; 10(2):93-100. PubMed ID: 27440210
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in people with a psychotic illness: is cannabis protective?
Waterreus A; Di Prinzio P; Watts GF; Castle D; Galletly C; Morgan VA
Psychol Med; 2016 Jun; 46(8):1651-62. PubMed ID: 26965714
[TBL] [Abstract][Full Text] [Related]
14. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders.
Jablensky A; McGrath J; Herrman H; Castle D; Gureje O; Evans M; Carr V; Morgan V; Korten A; Harvey C
Aust N Z J Psychiatry; 2000 Apr; 34(2):221-36. PubMed ID: 10789527
[TBL] [Abstract][Full Text] [Related]
15. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders.
Morgan VA; Morgan F; Galletly C; Valuri G; Shah S; Jablensky A
Soc Psychiatry Psychiatr Epidemiol; 2016 Feb; 51(2):269-79. PubMed ID: 26581211
[TBL] [Abstract][Full Text] [Related]
17. Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries.
Stubbs B; Koyanagi A; Veronese N; Vancampfort D; Solmi M; Gaughran F; Carvalho AF; Lally J; Mitchell AJ; Mugisha J; Correll CU
BMC Med; 2016 Nov; 14(1):189. PubMed ID: 27871281
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic Risk in First Episode Psychosis Patients.
Smith J; Griffiths LA; Band M; Horne D
Front Endocrinol (Lausanne); 2020; 11():564240. PubMed ID: 33329382
[TBL] [Abstract][Full Text] [Related]
19. Psychotic Experiences and Neuropsychological Functioning in a Population-based Sample.
Mollon J; David AS; Morgan C; Frissa S; Glahn D; Pilecka I; Hatch SL; Hotopf M; Reichenberg A
JAMA Psychiatry; 2016 Feb; 73(2):129-38. PubMed ID: 26720073
[TBL] [Abstract][Full Text] [Related]
20. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being.
Degenhardt L; Hall W
Psychol Med; 2001 May; 31(4):659-68. PubMed ID: 11352368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
